Automatic bone scan index for therapy response assessment of radium-223-dichloride (Ra-223) therapy in advanced prostate cancer

被引：0
|
作者：
Sakretz, M. [1 ]
Kurth, J. [1 ]
Schwarzenboeck, S. M. [1 ]
Krause, B. J. [1 ]
Heuschkel, M. [1 ]
机构：
[1] Univ Rostock, Dept Nucl Med, Med Ctr, D-18055 Rostock, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P748
引用
收藏
页码：S699 / S699
页数：1
相关论文
共 50 条
  • [1] Bone scan index as metastatic bone disease quantifier and predictor of radium-223-dichloride biochemical response
    Roque, Valentin
    Jessop, Maryam
    Pereira, Luisa
    Gape, Paul
    Dizdarevic, Sabina
    Sousa, Eva
    Carolino, Elizabete
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (06) : 588 - 596
  • [2] Radium-223-Dichloride in Castration-Resistant Metastatic Prostate Cancer: Therapy Assessment with 11C-choline PET/CT and Bone Scan
    Ghedini, P.
    Graziani, T.
    Rizzini, E. Lodi
    Lima, G.
    Bossert, I.
    Ceci, F.
    Montini, G.
    Pettinato, C.
    Monari, F.
    Dionisi, V.
    Morganti, A.
    Castellucci, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S131 - S132
  • [3] Imaging response during therapy (tx) with radium-223 (Ra-223) for castrate resistant prostate cancer (CRPC) with bone metastases (BM)
    Keizman, Daniel
    Peer, Avivit
    Neumann, Avivit
    Rosenbaum, Eli
    Neiman, Victoria
    Gottfried, Maya
    Kuchuk, Iryna
    Sarid, David
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [4] Radium Ra 223 Alpha Therapy for Prostate Cancer Bone Metastasis
    Strane, Timothy
    RADIOLOGIC TECHNOLOGY, 2021, 92 (06) : 618 - 622
  • [5] Quantitative Assessment of Skeletal Tumor Burden in Bone Scintigraphy as a prognostic biomarker in Radium-223-dichloride Therapy
    Soeiro, P.
    Silva, R.
    Gil, P.
    Pena, H.
    Cantinho, G.
    Costa, G.
    Lima, A.
    Ferreira, I.
    Alburqueque, A.
    Gouveia, P.
    Pedroso Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S566 - S567
  • [6] Imaging response during therapy with radium-223 (Ra-223) for castration-resistant prostate cancer (CRPC) with bone metastases (BM): A multicenter analysis.
    Omlin, Aurelius Gabriel
    Daugaard, Gedske
    Peer, Avivit
    Reichegger, Hermann
    Neumann, Avivit
    Rosenbaum, Eli
    Desax, Marie-Claire
    Neiman, Victoria
    Petersen, Peter Meidahl
    Mueller, Joachim
    Cathomas, Richard
    Gottfried, Maya
    Sarid, David
    Gez, Eli
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Mortensen, Jann
    Gillessen, Silke
    Keizman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Single-Institution Experience With Radium-223 Dichloride (Ra-223) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Cox, B. W.
    Wang, L.
    Bradley, T.
    Gu, B.
    Kelley, K.
    Potters, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S470 - S470
  • [8] Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?
    Gayed, Isis
    Salama, Vivian
    Dawood, Lydia
    Canfield, Steven
    Wan, David
    Cai, Chunyan
    Joseph, Usha
    Amato, Robert
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3317 - 3324
  • [9] 223Ra-Dichloride therapy in Prostate Cancer: Portuguese reality
    Monteiro, L.
    Carvalho, A. L.
    Vieira, D.
    Costa, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S761 - S761
  • [10] Radium-223 Therapy of Bone Metastases in Prostate Cancer
    Nilsson, Sten
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (06) : 544 - 556
12345